James Kearns, MD
Urology · Glenview, ILNPI 1316269228
Payments from drug & device makers
What this record shows
The money is spread across several categories — consulting fees (35.0%), food and beverage and travel and lodging — rather than concentrated in one kind of arrangement. Procept Biorobotics Corporation accounts for 74.6% of it on its own, with 4 other manufacturers making up the rest. 2025 is the largest year on record at $22,818, 3.1 times the $7,301 reported in 2019. Among urology clinicians in IL with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 38 payments — averaging $804.94 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Procept Biorobotics Corporation$23K
- Angiodynamics, Inc.$7K
- Blue Earth Diagnostics$177
- Olympus America Inc.$172
- Biom'up France SAS$105
What the payments were for
- Consulting fees$10,70035%
- Travel & lodging$9,72332%
- Food & beverage$10,16433%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Procept Biorobotics Corporation | 31 | $22,833 |
| Angiodynamics, Inc. | 1 | $7,301 |
| Blue Earth Diagnostics | 2 | $177 |
| Olympus America Inc. | 3 | $172 |
| Biom'up France SAS | 1 | $105 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- AquaBeam Robotic System$22,211
- iTIND System$150
- POSLUMA$135
- HemoBlast Bellows$105
How this compares
$30,588 in reported general payments places this provider in the 90th percentile of 550 urology providers in Illinois.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| MyrbetriqMirabegron | 15 | $17,632 |
| Tamsulosin Hcl | 383 | $6,368 |
| Solifenacin Succinate | 36 | $994 |
| Finasteride | 61 | $797 |
| Alfuzosin Hcl ErAlfuzosin Hcl | 30 | $755 |
| Oxybutynin Chloride ErOxybutynin Chloride | 18 | $650 |
| Levofloxacin | 181 | $209 |
| Diazepam | 15 | $20 |
Paid to pharmacies, not to this prescriber.
Other urology in Glenview
- Alexander GlaserGlenview$34K
- Kristian NovakovicGlenview$19K
- Mark BrandtPark Ridge$1.3M
- Aaron BergerChicago Ridge$583K
- Gary SteinbergChicago$529K
- Simone CrivellaroChicago$526K
- Brian HelfandChicago$517K
- Ashley RossChicago$404K
- Kevin McVarySpringfield$372K
- Richard HarrisMelrose Park$363K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.